home / stock / adil / adil news

ADIL News and Press, Adial Pharmaceuticals Inc From 02/28/24

Stock Information
Company Name: Adial Pharmaceuticals Inc
Stock Symbol: ADIL
Market: NASDAQ
Website: adialpharma.com
Menu
ADIL ADIL Quote ADIL Short ADIL News ADIL Articles ADIL Message Board
Get ADIL Alerts

News, Short Squeeze, Breakout and More Instantly...
ADIL - Adial Pharmaceuticals Awarded New United States Patent

2024-02-28 10:56:33 ET DENVER, Colo., Feb 28, 2024 ( 247marketnews.com )- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) said, this morning, that it was awarded a new patent, number 11,905,562, issued on February 20, 2024 by the United States Patent and Trademark Office, which covers t...
ADIL - Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

CHARLOTTESVILLE, Va., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...

ADIL - Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

CHARLOTTESVILLE, VA / ACCESSWIRE / February 15, 2024 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)(NASDAQ:ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announc...

ADIL - Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office

CHARLOTTESVILLE, Va., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...
ADIL - Adial Pharmaceuticals appoints Tony Goodman as COO

2024-01-18 08:41:42 ET More on Adial Pharmaceuticals Adial Pharmaceuticals stock plummets on selling 1.42M shares at $2.82 in private placement For further details see: Adial Pharmaceuticals appoints Tony Goodman as COO

ADIL - Adial Announces Appointment of Tony Goodman as Chief Operating Officer

Charlottesville, Va., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...

ADIL - Adial Pharmaceuticals files for $100M mixed shelf

2024-01-12 16:56:47 ET Adial Pharmaceuticals ( NASDAQ: ADIL ) on Friday filed a prospectus for a mixed securities shelf offering of up to $100M. This prospectus is not an offer to sell these securities. SEC Filing For further details see: Adial Pharmaceutical...
ADIL - Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate

CHARLOTTESVILLE, Va., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...

ADIL - Adial Pharmaceuticals regains compliance with Nasdaq listing rule

2023-11-29 16:08:29 ET More on Adial Pharmaceuticals Adial Pharmaceuticals stock plummets on selling 1.42M shares at $2.82 in private placement Seeking Alpha’s Quant Rating on Adial Pharmaceuticals For further details see: Adial Pharmaceuticals regains com...

ADIL - Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement

CHARLOTTESVILLE, Va., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...
Previous 10 Next 10